Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been in use since 1958. A variety of these inhibitors are under test as potential anti-inflammatory drugs. This book summarizes the developments, as well as giving a comprehensive description of the compounds available.